MSF expresses concern over proposed FY13 spending reduction for PEPFAR

NewsGuard 100/100 Score

Medical aid organization Medecins Sans Frontieres (MSF) has expressed concern over proposed cuts to PEPFAR under the White House FY 2013 budget proposal, "saying it will undermine the president's own goals" of "treat[ing] six million people infected with HIV around the world by the end of 2013," VOA News reports. While President Obama "has pledged to expand PEPFAR to include more people, his budget proposal for the fiscal year 2013 cuts more than a half-billion dollars from" bilateral HIV/AIDS programs, VOA writes.

"Jennifer Cohn, the East Africa policy adviser for the MSF Access Campaign, said she is concerned that countries that receive PEPFAR support may begin scaling back their own treatment programs in anticipation of the cuts," according to the news service. "PEPFAR senior adviser Tom Walsh said all the budget figures being discussed are preliminary and that some of the country figures are certain to change," VOA writes, adding, "Still, he emphasized that PEPFAR has made dramatic gains in efficiency, and that the budget requested for 2013 is the amount needed" (Joselow, 4/10).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug candidates show promise to reverse HIV immune evasion